Application of a commercial serodiagnostic kit that measures the serum anti-glycopeptidolipid core IgA antibody in Mycobacterium avium complex pulmonary disease

Association between serum anti-glycopeptidolipid-core IgA antibody titers and clinical characteristics of Mycobacterium avium complex pulmonary disease

“…The cutoff value was defined as 0.7 U/mL, according to the manufacturer's instructions (Kitada et al, 2008). The test can be performed using a small amount of serum, and the turnaround time is approximately 4 hours (Kitada, 2019).…”

Association between Serum Anti-glycopeptidolipid-core IgA Antibody Titers and Clinical Characteristics of Mycobacterium Avium Complex Pulmonary Disease

“…The cutoff value was de ned as 0.7 U/mL, according to the manufacturer's instructions [22]. The test can be performed using a small amount of serum, and the turnaround time is approximately 4 hours [32].…”

Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease

“…The seropositive rates of anti-GPL-core and anti-MBGL antibodies at enrollment were 72.9% and 74.1%, respectively, similar to those reported in previous studies. They increased to 85.9% and 92.9%, respectively, during follow-up ( 21 , 23 , 38 ). The exacerbation of lung lesions, indicated by the expansion of lesions and appearance of cavities, and the sputum smear test persistently positive for AFB might be associated with the increase in seropositive rates during follow-up, as in patients with chronic and active pulmonary TB ( 20 ).…”